Cancer research in the global village

Affiliations

Comment

Alastair J Munro et al. Lancet. 2010.

. 2010 Aug 28;376(9742):659-60.

doi: 10.1016/S0140-6736(10)61022-7. Epub 2010 Aug 19.

¹ Department of Surgery and Molecular Oncology, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. a.j.munro@dundee.ac.uk

No abstract available

Comment in

Trastuzumab for gastric cancer treatment.
Okines AF, Dewdney A, Chau I, Rao S, Cunningham D. Okines AF, et al. Lancet. 2010 Nov 20;376(9754):1736; author reply 1736-7. doi: 10.1016/S0140-6736(10)62127-7. Lancet. 2010. PMID: 21093643 No abstract available.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kang YK; ToGA Trial Investigators. Bang YJ, et al. Lancet. 2010 Aug 28;376(9742):687-97. doi: 10.1016/S0140-6736(10)61121-X. Epub 2010 Aug 19. Lancet. 2010. PMID: 20728210 Clinical Trial.